Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -5,650 | -7,720 | N/A | N/A |
| Depreciation Amortization | N/A | 110 | 160 | N/A | N/A |
| Other Working Capital | N/A | -380 | -820 | N/A | N/A |
| Other Operating Activity | 0 | 1,330 | 2,100 | 0 | 0 |
| Operating Cash Flow | $N/A | $-4,590 | $-6,280 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -130 | -150 | N/A | N/A |
| Other Investing Activity | 0 | 4,180 | 5,490 | 0 | 0 |
| Investing Cash Flow | $N/A | $4,050 | $5,340 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 2,960 | 3,310 | 0 | 0 |
| Financing Cash Flow | $N/A | $2,960 | $3,310 | $N/A | $N/A |
| Beginning Cash Position | N/A | 2,150 | 2,310 | N/A | N/A |
| End Cash Position | N/A | 4,580 | 4,680 | N/A | N/A |
| Net Cash Flow | $N/A | $2,420 | $2,370 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -4,590 | -6,280 | N/A | N/A |
| Free Cash Flow | 0 | -4,590 | -6,280 | 0 | 0 |